Enter inventor name

Michel Auguet

This inventor holds 21 USPTO granted patents, plus 3 CIPO patents and 7 EPO patents. Top assignees: Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.), Ipsen Pharma S.a.s., Societe De Conseils De Recherches Et D'applications Scientifiques. Active years: 1992-2018.

USPTO Granted Patents = 21

% Patents Active = 33.3

CIPO Patents = 3

EPO Patents = 7 (Patent Applications = 2)

Average Co-Inventor Count = 3.2

ph-index = 7

Forward Citations = 137(Granted Patents)

Company Filing History:

12 out of 119

Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.)

Societe De Conseils De Recherches Et D'applications Scientifiques

patents

Years Active: 1992-2018

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9918967 - Thiazole derivatives for treating dyskinesias caused by a chemical treatment (2018-03-20),

2. 9259458 - Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy (2016-02-16),

3. 9080220 - Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative (2015-07-14),

4. 9006274 - Thiazole derivatives for treating dyskinesias caused by a chemical treatment (2015-04-14),

5. 8921322 - Use of at least one botulinum neurotoxin for treating the pain induced by therapeutic treatments for the AIDS virus (2014-12-30),

6. 8784841 - Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy (2014-07-22),

7. 8273359 - Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agent (2012-09-25),

8. 7345066 - Use of thiazole derivatives for preparing a medicine for protecting mitochondria (2008-03-18),

9. 7285664 - Heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments (2007-10-23),

10. 6936715 - Lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines (2005-08-30),

11. 6887891 - Derivatives of lipoic acid, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2005-05-03),

12. 6872738 - Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance (2005-03-29),

13. 6809088 - Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2004-10-26),

14. 6630461 - Derivatives of 2-(iminomethyl) amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them (2003-10-07),

15. 6605637 - Lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them (2003-08-12),

Title: Michel Auguet: Innovator in Medicinal Compounds

Introduction

Michel Auguet is a prominent inventor based in Palaiseau, France, known for his contributions to medicinal chemistry. With a remarkable portfolio of 21 patents, he has been instrumental in developing innovative therapies for various medical conditions.

Latest Patents

Among his latest patents, one notable invention is titled "Thiazole derivatives for treating dyskinesias caused by a chemical treatment." This invention revolves around the use of thiazole derivatives characterized by a specific general formula for creating a medication aimed at treating or preventing dyskinesias caused by chemical treatments. Additionally, it includes combinations of these thiazole derivatives with neuroleptics or drugs that affect the dopaminergic system.

Another significant patent from Michel concerns the "Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy." This groundbreaking invention focuses on the administration of botulinum neurotoxins for treating pain linked to diabetic neuropathy, with a novel approach of local administration away from the central nervous system.

Career Highlights

Michel Auguet has had a notable career in the pharmaceutical industry. He has worked with esteemed organizations such as Société de Conseils de Recherches et d'Applications Scientifiques (SCRAS) and Ipsen Pharma S.A.S. His experience in these companies has significantly influenced his research and innovative contributions to the field.

Collaborations

Collaboration has been a vital aspect of Michel's career. He has partnered with distinguished colleagues, including Jeremiah Harnett and Pierre-Etienne Chabrier de Lassauniere, helping to foster a synergistic environment that enhances the innovation process and leads to successful outcomes in his projects.

Conclusion

In conclusion, Michel Auguet stands out as a significant contributor to medicinal innovations with his extensive patent portfolio and collaboration with other skilled professionals. His advancements in therapies for dyskinesias and diabetic neuropathy not only demonstrate his inventive prowess but also highlight his commitment to improving patient outcomes through scientific innovation.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]